Thirty Madison vs Noom

Side-by-side comparison of AI visibility scores, market position, and capabilities

Noom leads in AI visibility (86 vs 72)
Thirty Madison logo

Thirty Madison

LeaderHealthcare

Condition-Specific Telehealth Platform

Thirty Madison is a condition-specific telehealth company operating Keeps (hair loss), Facet (migraines), Evens (acid reflux), and Nurx (sexual/reproductive health); raised $140M+ total including a $140M Series C in 2021;

AI VisibilityBeta
Overall Score
B72
Category Rank
#114 of 596
AI Consensus
76%
Trend
stable
Per Platform
ChatGPT
78
Perplexity
75
Gemini
76

About

Thirty Madison is a healthcare company founded in 2018 and headquartered in New York City that builds specialized direct-to-patient brands for chronic conditions. Rather than operating a single general telehealth platform, the company pursues a brand-per-condition strategy: each subsidiary is purpose-built with condition-specific clinical protocols, user experience, and product formularies. Its portfolio includes Keeps (hair loss), Facet (migraines), Evens (acid reflux and heartburn), and Nurx (sexual health, reproductive health, and mental health), alongside its legacy Thirty Madison brand for migraine care.

Full profile
Noom logo

Noom

GrowthHealthcare

Weight Health Platform

Noom is a digital weight health program combining psychology-based behavioral coaching, food logging, and human coaching to help members build sustainable healthy habits.

AI VisibilityBeta
Overall Score
A86
Category Rank
#12 of 596
AI Consensus
67%
Trend
stable
Per Platform
ChatGPT
80
Perplexity
81
Gemini
92

About

Noom is a digital health company founded in 2008 that has grown into one of the most widely used weight management platforms, serving millions of members through its psychology-driven approach to behavior change. The platform combines daily lessons on cognitive behavioral techniques, food logging with a traffic-light color-coding system, personal coaching from trained health coaches, and group support to help members change their relationship with food and exercise. Noom raised over $540M and reached a $3.7B valuation, establishing it as a leading consumer digital health company. The company has expanded beyond weight loss into a broader weight health platform addressing both weight management and weight-related conditions including type 2 diabetes management with its Noom Med offering that includes GLP-1 medication prescribing. As GLP-1 medications like Ozempic and Wegovy have transformed the weight loss market, Noom has positioned its behavioral coaching as essential to sustainable results alongside medication. The platform serves both direct-to-consumer subscribers and employer health plans that offer Noom as a weight management benefit for their workforces.

Full profile

AI Visibility Head-to-Head

72
Overall Score
86
#114
Category Rank
#12
76
AI Consensus
67
stable
Trend
stable
78
ChatGPT
80
75
Perplexity
81
76
Gemini
92
70
Claude
90
69
Grok
83

Key Details

Category
Condition-Specific Telehealth Platform
Weight Health Platform
Tier
Leader
Growth
Entity Type
brand
brand

Capabilities & Ecosystem

Capabilities

Only Noom
Weight Health Platform

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.